The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells

Clinical Cancer Research

Volumn 5, Issue 1, 1999, Pages 119-127

  Wang, Weixin ^a   Abbruzzese, James L ^a   Evans, Douglas B ^a   Larry, Lillie ^a   Cleary, Karen R ^a   Chiao, Paul J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; RAF PROTEIN;

ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; TRANSACTIVATION;

ADENOCARCINOMA; ADULT; AMINO ACID SEQUENCE; ANIMALS; CRICETINAE; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; MESOCRICETUS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PANCREATIC NEOPLASMS; POINT MUTATION; TRANSCRIPTION FACTOR RELA; TUMOR CELLS, CULTURED;

EID: 0032943591     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1997. CA Cancer J. Clin., 47: 5-27, 1997.
2. DiGiuseppe, J. A., Yeo, C. J., and Hruban, R. H. Molecular biology and the diagnosis and treatment of adenocarcinoma of the pancreas. Adv. Anat. Pathol., 3: 139-155, 1996.
3. Staley, C. A., Lee, J. E., Cleary, K. A., Abbruzzese, J. L., Ames, F. C., Fenoglio, C., and Evans, D. B. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head: patient survival and patterns of treatment failure. Am. J. Surg., 171: 118-124, 1996.
4. Evans, D. B., Abbruzzese, J. L., Lee, J. E., Leach, S. D., Charnsangavej, C., Cleary, K. R., Buchholz, D. J., and Rich, T. A. Preoperative chemoradiation for adenocarcinoma of the pancreas: MD Anderson experience. Semin. Surg. Oncol., 11: 132-142, 1995.
5. Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., DaCosta, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 277: 350-353, 1996.
6. Verma, I. M., Stevenson, J. K., Schwarz, E. M., Antwerp, D. V., and Miyamoto, S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev., 9: 2723-2735, 1995.
7. Baldwin, A., Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol., 14: 694-681, 1996.
8. Bacuerle, P. A., Baltimore, D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science (Washington DC), 242: 540-546, 1988.
9. Grilli, M., Chiu, J, J. S., and Lenardo, M. J. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol., 143: 1-62, 1993.
10. Chiao, P. J., Miyamoto, S., and Verma, I. M. Autoregulation of 1κBα activity. Proc. Natl. Acad. Sci. USA, 91: 28-33, 1994.
11. Miyamoto, S., Chiao, P. J., and Verma, I. M. Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines. Mol. Cell. Biol., 14: 3276-3282, 1994.
12. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Sieben-list, U. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science (Washington DC), 267: 1485-1488, 1995.
13. Chen, Z. J., Hagler, J., Palombella, V. J., Melandri, F., Scherer, D., Ballard, D., and Maniatis, T. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev., 9: 1586-1597, 1995.
14. Didonato, J. A., Mercurio, F., and Karin, M. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB. Mol. Cell Biol., 15: 1302-1311, 1995.
15. Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J., Young, D. B., Barbosa, M., Mann, M., Manning, A., and Rao, A. IKK-1, and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science (Washington DC), 278: 860-866, 1997.
16. Woronicz, J. D., Gao, X., Cao, Z., Rothe, M., and Goeddel, D. V. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science (Washington DC), 278: 866-869, 1997.
17. DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., and Karin, M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature (Lond.), 388: 548-554, 1997.
18. Regnier, C. H., Song, H. Y., Gao, X., Goeddel, D. V., Cao, Z., and Rothe, M. Identification and characterization of an IκB kinase. Cell, 90: 373-383, 1997.
19. Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., and Karin, M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell, 91: 243-252, 1997.
20. Hirano, M., Osada, S., Aoki, T., Hirai, S., Hosaakka, M., Inoue, J., and Ohno, S. MEK kinase is involved in tumor necrosis factor α-induced NF-κB activation and degradation of IκBα. J. Biol. Chem., 271: 13234-13238, 1996.
21. Lee, F. S., Hagler, J., Chen, Z., and Maniatis, T. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell, 88: 213-222, 1997.
22. Gilmore, T. D., Koedood, M., Piffat, K. A., and White, D. Rel/NF-κB/IκB proteins and cancer. Oncogene, 14: 1367-1378, 1997.
23. Neri, A., Chang, C. C., Lombardi, L., Salina, M., Corradini, P., Maiolo, A. T.; Chaganti, R. S. K., and Dalla-Favera, R. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell, 67: 1075-1087, 1991.
24. Liptay, S., Schmid, R. M., Perkins, N. D., Meltzer, P., Altherr, M. R., McPherson, J. D., Wasmuth, J. J., and Nabel, G. J. Related subunits of NF-κB map to two distinct loci associated with translocations in leukemia: NFKB1 and NFKB2. Genomics, 13: 287-292, 1992.
25. Ohno, H., Takimoto, G., and McKeithan, T. W. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell, 60: 991-997, 1990.
26. Lu, D., Thompson, J. D., Gorski, G. K., Rice, N. R., Mayer, M. G., and Yunis, J. J. Alterations of the rel locus in human lymphoma. Oncogene, 6: 1235-1241, 1991.
27. Moore, B. E., and Bose, H. R. Transformation of avian lymphoid cells by reticuloendotheliosis virus. Mutat. Res., 795: 79-80, 1988.
28. Moore, B. E., and Bose, H. R. J. Expression of the v-rel oncogene in reticuloendotheliosis virus-transformed fibroblasts. Virology, 162: 377-387, 1988.
29. Sylla, B. S., and Temin, H. M. Activation of oncogenicity of the c-rel proto-oncogene. Mol. Cell. Biol., 6: 4709-4716, 1986.
30. Beauparlant, P., Kwan, I., Bitaar, R., Chou, P., Koromilas, A. E., Sonenberg, N., and Hiscott, J. Disruption of IκBα regulation by antisense RNA expression leads to malignant transformation. Oncogene, 9: 3189-3197, 1994.
31. Kitajima, I., Shinohara, T., Bilakovics, J. D. A. B., Xu, X., and Nerenberg, M. Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science (Washington DC), 258: 1792-1795, 1992.
32. Finco, T. S., Baldwin, A. S., Jr. Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1. J. Biol. Chem., 268: 17676-17679, 1993.
33. Brader, J. T., Heidecker, G., Tan, T. H., Weske, J. C., Derse, D., and Rapp, U. R. Oncogene activation of HIV-LTR-driven expression via the NF-kappa B binding sites. Nucleic Acids Res., 21: 5229-5234, 1993.
34. Mayo, M. W., Wang, C. Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J., and Baldwin, A. S., Jr. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science (Washington DC), 278: 1812-1815, 1997.
35. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most human carcinomas of the human exocrine pancreas contain mutant c-K-ras genes. Cell, 53: 549-554, 1988.
36. Zable, U., Henkel, T., Silva, M. D. S., and Bacuerle, P. Nuclear uptake control of NF-κB by MAD-3, an IκB protein in the nucleus. EMBO J., 12: 201-211, 1993.
37. Andrews, N. C., and Faller, D. V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res., 19: 2499, 1991.
38. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
39. Abbruzzese, J. L., Evans, D. B., Raijman, I., Larry, L., King, T., Leach, S. D., and Frazier, M. L. Detection of mutated c-Ki-ras in the bile of patients with pancreati cancer. Anticancer Res., 17: 795-801, 1997.
40. Evans, D. B., Frazier, M. L., Charnsangavej, C., Katz, R. L., Larry, L., and Abbruzzese, J. L. Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique. Ann. Surg. Oncol., 3: 241-246, 1996.
41. Singh, S., and Aggarwal, B. B. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J. Biol. Chem., 270: 24995-25000, 1995.
42. Korutla, L., and Kumar, R. Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim. Biophys. Acta, 1224: 597-600, 1994.
43. Wang, C. Y., Mayo, M. W., and Baldwin, A., Jr. TNF- and cancer therapy-induced apoptosis potentiation by inhibition of NF-κB. Science (Washington DC), 274: 784-787, 1996.
44. Van Antwerp, D., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science (Washington DC), 274: 787-789, 1996.
45. Hall, P. A., and Lemoine, N. R. Models of pancreatic cancer. Cancer Surv., 16: 135-155, 1993.
46. Longnecker, D. S., Wiebikin, N. M., Schaeffer, B. K., and Roebuck, B. D. Experimental carcinogenesis in the pancreas. Int. Rev. Exp. Pathol., 26: 177-229, 1984.
47. Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M., and Sonenshein, G. E. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest., 100: 2952-2960, 1997.
48. Perez, P., Lira, S. A., and Bravo, R. Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein I kappa Bα. Mol. Cell. Biol., 7: 3523-3530, 1995.
49. Beg, A. A., and Baltimore, D. An essential role of NF-κB in preventing TNF-α-induced cell death. Science (Washington DC), 274: 782-784, 1996.
50. Finco, T. S., Westwick, J. K., Norris, J. L., Beg, A. A., Der, C. J., and Baldwin, A. S., Jr. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. J. Biol. Chem., 272: 24113-24116, 1997.
51. Minden, A., Lin, A., McMahon, M., Lange-Carter, C., Derijard, B., Davis, R. J., Johnson, G. L., and Karin, M. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science (Washington DC), 266: 1719-1723, 1997.
52. Russell, M., Lange-Carter, C. A., and Johnson, G. L. Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase (MEKK1). J. Biol. Chem., 270: 11757-11760, 1995.